Nitric oxide synthases: Properties and catalytic mechanism

Annual Review of Physiology

Volumn 57, Issue , 1995, Pages 707-736

  Griffith, Owen W ^a   Stuehr, Dennis J ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

heme cofactor; NOS inhibitors; NOS isoforms; reductase and oxygenase domains; tetrahydrobiopterin

Indexed keywords

6 N ETHYLARGININE; ARGININE; ARGININE DERIVATIVE; CLOTRIMAZOLE; KETOCONAZOLE; MICONAZOLE; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

EID: 0028902552     PISSN: 00664278     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.57.1.707     Document Type: Review

References (149)

1. Abu-Soud HM, Stuehr DJ. 1993. Nitric oxide synthases reveal a role for calmodulin in controlling electron transfer. Proc. Natl. Acad. Sci. USA 90:10769-72
2. Albina JE, Mills CD, Henry WL Jr, Caldwell MD. 1990. Temporal expression of different pathways of L-arginine metabolism in healing wounds. J. Immunol. 144:3877-80
3. Archer S. 1993. Measurement of nitric oxide in biological models. FASEB J. 7:349-60
4. Arnold WP, Mittal CK, Katsuki S, Murad F. 1977. Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations. Proc. Natl. Acad. Sci. USA 74:3203-7
5. Babbedge RC, Bland-Ward PA, Hart SL, Moore PK. 1993. Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles. Br. J. Pharmacol. 110:225-28
6. Baek KJ, Thiel BA, Lucas S, Stuehr DJ. 1993. Macrophage nitric oxide synthase subunits. J. Biol. Chem. 268:21120-29
7. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, et al. 1991. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351:714-18
8. Bredt DS, Hwang PM, Snyder SH. 1990. Localization of nitric oxide synthase indicating a neuronal role for nitric oxide. Nature 347:768-70
9. Bredt DS, Snyder SH. 1990. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA 87:682-85
10. Bredt DS, Snyder SH. 1994. Nitric oxide: a physiologic messenger molecule. Annu. Rev. Biochem. 63:175-95
11. Buga GM, Gold ME, Fukuto JM, Ignarro LJ. 1991. Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension 17:187-93
12. Busconi L, Michel T. 1993. Endothelial nitric oxide synthase. N-terminal myristoylation determines subcellular localization. J. Biol. Chem. 268:8410-13
13. G-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ. Res 72:387-95
14. Charles IG, Chubb A, Gill R, Clare J, Lowe PN, et al. 1993. Cloning and expression of a rat neuronal nitric oxide synthase coding sequence in a baculo-virus/insect cell system. Biochem. Biophys. Res. Commun. 196:1481-89
15. Charles IG, Palmer RMJ, Hickery MS, Bayliss MT, Chubb AP, et al. 1993. Cloning, characterization and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proc. Natl. Acad. Sci. USA 90: 11419-23
16. Cho JH, Xie QW, Calaycay J, Mumford RA, Swiderek KM, et al. 1992. Calmodulin is a subunit of nitric oxide synthase from macrophages. J. Exp. Med. 176:599-604
17. Clement B, Schultze-Mosgau MH, Richter PH, Besch A. 1994. Cytochrome P450-dependent N-hydroxylation of an amino guanidine (amidinohydrazone) and microsomal retroreduction of the N-hydroxylated product. Xenobiotica 24:671-88
18. ω-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J. Exp. Med. 176:1175-82
19. Cochran FR. 1994. Inhibition of nitric oxide synthesis as a therapeutic target for arthritis: recent reports. Exp. Opin. Invest. Drugs 34:529-31
20. Corbett JA, Tilton RG, Chang K, Hasan KS, Ido Y, et al. 1992. Aminoguanidine, a novel inhibitor of nitric oxide forma-tion, prevents diabetic vascular dysfunction. Diabetes 41:552-56
21. Craven PA, Derubertis FR. 1978. Restoration of the responsiveness of purified guanylate cyclase to nitrosoguanidine, nitric oxide, and related activators by heme and heme proteins: Evidence for the involvement of the paramagnetic nitrosyl-heme complex in enzyme activation. J. Biol. Chem. 253: 8433-43
22. Dix TA, Kuhn DM, Benkovic SJ. 1987. Mechanism of oxygen activation by tyrosine hydroxylase. Biochemistry 26: 3354-61
23. Deleted in proof
24. Feelisch M, Noack EA. 1987. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur. J. Pharmacol. 139:19-30
25. G-methylarginine requires NADPH-dependent hydroxylation. J. Med. Chem. 36:491-96
26. Feldman PL, Griffith OW, Stuehr DJ. 1993. The surprising life of nitric oxide. Chem. Eng. News 71(51):26-38
27. Förstermann U, Nakane M, Tracey WR, Pollock JS. 1993. Isoforms of nitric oxide synthase: functions in the cardiovascular system. Eur. Heart J. 14(Suppl. 1):10-15
28. Förstermann U, Pollack JS, Schmidt HHW, Heller M, Murad F. 1991. Calmodulin-dependent endothelium derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc. Natl. Acad. Sci. USA 88:1788-92
29. Frey C, Narayanan K, McMillan K, Spack L, Gross S, et al. 1994. L-thiocitrulline: a stereospecific, heme-binding inhibitor of nitric oxide synthase. J. Biol. Chem. 269: In press
30. Fukuto JM, Hobbs AJ, Ignarro LJ. 1993. Coversion of nitroxyl (HNO) to nitric oxide (NO) in biological systems: the role of physiological oxidants and relevance to the biological activity of HNO. Biochem. Biophys. Res. Commun. 196: 707-13
31. G-amino-L-arginine: a new potent antagonist of L-arginine-mediated endothelium-dependent relaxation. Biochem. Biophys. Res. Commun. 168:458-65
32. Furchgott RF. 1984. The role of endothelium in the responses of vascular smooth muscle to drugs. Annu. Rev. Pharmacol. Toxicol. 24:175-97
33. Furchgott RF. 1988. Studies on relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that the acid-activatable inhibitory factor from bovine retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide. In Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves, and Endothelium, ed. PM Vanhoutte, pp. 401-14. New York: Raven
34. Furchgott RF, Zawadzki JV. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373-76
35. G-nitroarginine. Biochemistry 32: 8512-17
36. Garthwaite J, Charles SL, Chess-Williams R. 1988. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336:385-88
37. Garvey EP, Tuttle JV, Covington K, Merrill BM, Wood ER, et al. 1994. Purification and characterization of the constitutive nitric oxide synthase from human placenta. Arch. Biochem. Biophys. 311:235-41
38. Gaston B, Reilly J, Drazen JM, Fackler J, Ramdev P, et al. 1993. Endogenous nitrogen oxides and bronchodilator Snitrosothiols in human airways. Proc. Natl. Acad. Sci. USA 90:10957-61
39. Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, Di Silvio M, et al. 1993. Molecular cloning and expression of inducible nitric oxide synthase from human heptatocytes. Proc. Natl. Acad. Sci. USA 90:3491-95
40. Giovanelli J, Campos KL, Kaufman S. 1991. Tetrahydrobiopterin, a cofactor for rat cerebellar nitric oxide synthase does not function as a reactant in the oxygenation of arginine. Proc. Natl. Acad. Sci. USA 88:7091-95
41. 15N]nitrate in biological fluids. Anal. Biochem. 126:131-38
42. Griscavage JM, Rogers NE, Sherman MP, Ignarro LJ. 1993. Inducible nitric oxide synthase from a rat alveolar macrophage cell line is inhibited by nitric oxide. J. Immunol. 151:6329:37
43. Gross SS, Levi R. 1992. Tetrahydro-biopterin synthesis. An absolute re-quirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J. Biol. Chem. 267:25722-29
44. G-methylarginine. Biochem. Biophys. Res. Commun. 170:96-103
45. Gruetter CA, Barry BK, McNamara DB, Gruetter DY, Kadowitz PJ, et al. 1979. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosamine. J. Cyclic Nucleotide Res. 5:211-24
46. 44a. Hasan K, Heesen BJ, Corbett JA, Mc-Daniel ML, Chang K, el al. 1993. Inhibition of nitric oxide formation by guanidines. Eur. J. Pharmacol. 249: 101-6
47. Hecker M, Sessa WC, Harris HJ, Ånggøard EE, Vane JR. 1990. The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine. Proc. Natl. Acad. Sci. USA 87:8612-16
48. 2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem. J. 281:627-30
49. Henry Y, Lepoivre M, Drapier JC, Ducrocq C, Boucher JL, et al. 1993. EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEB J. 7:1124-34
50. Hevel JM, Marietta MA. 1992. Macrophage nitric oxide synthase: relationship between enzyme-bound tetrahydrobiopterin and synthase activity. Biochemistry 31:7160-65
51. Hevel JM, Marietta MA. 1993. Macrophage nitric oxide synthase: tetrahydrobiopterin decreases the NADPH stoichiometry. Adv. Exp. Med. Biol. 338: 285-88
52. Hevel JM, White KA, Marletta MA. 1991. Purification of the inducible murine macrophage nitric oxide synthase. Identification as a flavoprotein. J. Biol. Chem. 266:22789-91
53. Hibbs JB Jr, Taintor RR, Vavrin Z, Rachlin EM. 1988. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Comm. 157:87-94
54. Hibbs JB Jr, Vavrin Z, Taintor RR. 1987. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol. 138: 550-65
55. Hobbs AJ, Fukuto JM, Ignarro LJ. 1994. Formation of free nitric oxide from L-arginine by nitric oxide synthase: direct enhancement of generation by superoxide dismutase. Proc. Natl. Acad. Sci. USA. 91:10992-96
56. Ignarro LJ. 1990. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu. Rev. Pharmacol. Toxicol. 30:535-60
57. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. 1987. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA 84: 9265-69
58. Ignarro U, Byrns RE, Woods KS. 1988. Biochemical and pharmacological properties of endothelium-derived relaxing factor and its similarity to nitric oxide radical. See Ref. 33, pp. 427-35
59. Ishii K, Sheng H, Warner TD, Förstermann U, Murad F. 1991. A simple and sensitive bioassay method for detection of EDRF with RFL-6 rat lung fibroblasts. Am. J. Physiol. 261:H598-603
60. Iyengar R, Stuehr DJ, Marietta MA. 1987. Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst. Proc. Natl. Acad. Sci. USA 84:6369-73
61. Janssens SP, Shimouchi A, Quertermous T, Bloch DB, Bloch KD. 1992. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J. Biol. Chem. 267:14519-22
62. Deleted in proof
63. Karupiah G, Xie QW, Buller ML, Nathan C, Duarte C, et al. 1993. Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science 261:31445-48
64. Kelm M, Feelisch M, Deussen A, Strauer BE, Schrader J. 1991. Release of endothelium derived nitric oxide in relation to pressure and flow. Cardiovasc. Res. 25:831-36
65. Kilbourn RG, Belloni P. 1990. Endothelial cell production of nitrogen oxides in response to interferon γ in combination with tumor necrosis factor, interleukin-1 or endotoxin. J. Natl. Canc. Inst. 82:772-76
66. Kilbourn RG, Griffith OW. 1992. Overproduction of nitric oxide in cytokine-mediated and septic shock. J. Natl. Canc. Inst. 84:827-31
67. G-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc. Natl. Acad. Sci. USA 87: 3629-32
68. ω-amino-L-arginine. J. Natl. Canc. Inst. 84:1008-16
69. G-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem. Biophys. Res. Commun. 172:1132-38
70. G-methyl-L-arginine, an inhibitor of nitric oxide formation, reverses IL-2-mediated hypotension in dogs. J. Appl. Physiol. 76:1130-37
71. 2+/calmodulin-dependent cytochrome c reductase activity of brain nitric oxide synthase. J. Biol. Chem. 267:11374-78
72. Klatt P, Schmid M, Leopold E, Schmidt K, Werner ER. 1994. The pteridine binding site of brain nitric oxide synthase. J. Biol. Chem. 269:13861-66
73. Klatt P, Schmidt K, Brunner F, Mayer B. 1994. Inhibitors of brain nitric oxide synthase. J. Biol. Chem. 269:1674-80
74. Klatt P, Schmidt K, Mayer B. 1992. Brain nitric oxide synthase is a haemoprotein. Biochem. J. 288:15-17
75. Klatt P, Schmidt K, Uray G, Mayer B. 1993. Multiple catalytic functions of brain nitric oxide synthase. J. Biol. Chem. 268:14781-87
76. Kobzik L, Bredt DS, Lowenstein CJ, Drazen J, Gaston B, et al. 1993. Nitric oxide synthase in human and rat lung: Immunocytochemical and histochemical localization. Am. J. Resp. Cell Mol. Biol. 9:371-77
77. ω-hydroxy-L-arginine to citrulline and nitric oxide. J. Biol. Chem. 269:17776-79
78. Kwon NS, Nathan CF, Gilker C, Griffith OW, Matthews DE, et al. 1990. L-citrulline production from L-arginine by macrophage nitric oxide synthase. The ureido oxygen derives from dioxygen. J. Biol. Chem. 265:13442-45
79. Kurzban GP, Strobel HW. 1986. Preparation and characterization of FAD-dependent NADPH cytochrome P-450 reductase. J. Biol. Chem. 261:7824-30
80. Lamas S, Marsden PA, Li GK, Gordon K, Tempst P, et al. 1992. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc. Natl. Acad. Sci. USA 89:6348-52
81. Lambert LE, Whitten JP, Baron BM, Cheng HC, Doherty NS, et al. 1991. Nitric oxide synthesis in the CNS, endothelium and macrophages differs in its sensitivity to inhibition by arginine analogues. Life Sci. 48:69-75
82. Leaf CD, Wishnok JS, Tannenbaum SR. 1989. L-arginine is a precursor for nitrate biosynthesis in humans. Biochem. Biophys. Res. Commun. 163:1032-37
83. Leone AM, Palmer RMJ, Knowles RG, Francis PL, Ashton DS, et al. 1991. Constitutive and inducible nitric oxide symhases incorporate molecular oxygen into both nitric oxide and citrulline. J. Biol. Chem. 266:23790-95
84. Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH. 1992. Cloned and expressed nitric oxide synthase contrasts with the brain enzyme. Proc. Natl. Acad. Sci. USA 89:6711-15
85. Lyons CR, Orloff GJ, Cunningham JM. 1992. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J. Biol. Chem. 267:6370-74
86. Malinski T, Taha Z. 1992. Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature 358:676-78
87. Marletta MA. 1993. Nitric oxide synthase structure and mechanism. J. Biol. Chem. 268:12231-34
88. Marletta MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JD. 1988. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 27:8706-11
89. Masters BSS. 1994. Nitric oxide synthases: why so complex? Annu. Rev. Nutr. 14:131-45
90. 2+/calmodulin-dependent nitric oxide synthase from porcine cerebellum: cofactor role of tetrahydrobiopterin. FEBS Lett. 277: 215-19
91. McCartney-Francis N, Allen JB, Mizel DE, Albina JE, Xie Q, et al. 1993. Suppression of arthritis by an inhibitor of nitric oxide synthase. J. Exp. Med. 178:749-54
92. McMillan K, Bredt DS, Hirsch DJ, Sny-der SH, Clark JE, et al. 1992. Cloned, expressed rat cerebellar nitric oxide synthase contains stoichiometric amounts of heme, which binds carbon monoxide. Proc. Natl. Acad. Sci. USA 89:11141-45
93. McMillan K, Masters BSS. 1993. Optical difference spectrophotometry as a probe of rat brain nitric oxide synthase heme-substrate interaction. Biochemistry 32:9875-80
94. Menon NK, Pataricza J, Binder T, Bing RJ. 1991. Reduction of biological effluents in purge and trap micro reaction vessels and detection of endolhelium-derived nitric oxide (edno) by chemiluminescence. J. Mol. Cell Cardiol. 23: 389-93
95. Misko TP, Moore WM, Kasten TP, Nickols GA, Corbett JA, et al. 1993. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol. 233:119-25
96. Moncada S, Palmer RMJ, Higgs EA. 1988. The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension 12:365-72
97. Deleted in proof
98. Murphy ME, Sies H. 1991. Reversible conversion of nitroxyl anion to nitric oxide by superoxide dismutase. Proc. Natl. Acad. Sci. USA 88:10860-64
99. Nakane M, Schmidt HHW, Pollock JS, Förstermann U, Murad F. 1993. Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett. 316:175-80
100. Narayanan K, Griffith OW. 1994. Synthesis of L-thiocitrulline, L-homothiocitrulline and S-methyl-L-thiocitrulline: a new class of potent nitric oxide synthase inhibitors. J. Med. Chem. 37:885-87
101. Narayanan K, Spack L, Hayward M, Griffith OW. 1994. S-methyl-L-thiocitrulline: a potent inhibitor of nitric oxide synthase with strong pressor activity in vivo. FASEB J. 8:A360
102. BM-3, a catalytically self-sufficient monooxygenase induced by barbiturates in Bacillus megaterium. J. Biol. Chem. 262:6683-90
103. Nathan C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051-64
104. Nathan CF, Hibbs JB Jr. 1991. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:65-70
105. Nathan CF, Xie QW. 1994. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269:13725-28
106. Nishida K, Harri son DG, Navas JP, Fisher AA, Dockery SP, et al. 1992. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J. Clin. Invest. 90:2092-96
107. Nunokawa Y, Ishida N, Tanaka S. 1993. Cloning of inducible nitric oxide synthase in rat vascular smooth muscle. Biochem. Biophys. Res. Commun. 191: 89-94
108. O'Dell TJ, Huang PL, Dwason TM, Dinerman JL, Snyder SH, et al. 1994. Endothelial NOS and the blockade of LTP by NOS inhibitors in mice lacking neuronal NOS. Science 265:542-46
109. G-cyclopropyl-L-arginine: two novel inhibitors of macrophage nitric oxide synthase. J. Med. Chem. 35: 1137-44
110. G-methyl-L-arginine functions as an alternate substrate and mechanism-based inhibitor of nitric oxide synthase. Biochemistry 32:9677-85
111. Palmer RMJ, Ashton DS, Moncada S. 1988. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333:664-66
112. Palmer RMJ, Ferrige AG, Moncada S. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-26
113. Petros A, Lamb G, Leone A, Moncada S, Bennett D, et al. 1994. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc. Res. 28: 34-39
114. Pollock, JS, Förstermann U, Mitchell JA, Warner TD, Schmidt, et al. 1991. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc. Natl. Acad. Sci. USA 88:10480-84
115. Porter TD, Coon MJ. 1991. Cytochrome P450. J. Biol. Chem. 266:13469-72
116. Pou S, Pou WS, Bredt DS, Snyder SS, Rosen GM. 1992. Generation of superoxide by purified brain nitric oxide synthase. J. Biol. Chem. 267:24173-76
117. G-hydroxy-L-arginine by nitric oxide synthase: evidence for the involvement of the heme in catalysis. Biochem. Biophys. Res. Commun. 193:963-70
118. Pufahl RA, Nanjappan PG, Woodard RW, Marietta MA. 1992. Mechanistic probes of N-hydroxylation of L-arginine by the inducible nitric oxide synthase from murine macrophages. Biochemistry 31:6822-28
119. ωhydroxyarginine to citrulline and nitrogenoxides and occurrence in NO synthases of a sequence very similar to the heme-binding sequence in P450s. Biochem. Biophys. Res. Commun. 192:53-60
120. Rogers NE, Ignarro LJ. 1992. Constitutive nitric oxide synthase from cerebellum is reversibly inhibited by nitric oxide formed from L-arginine. Biochem. Biophys. Res. Commun. 189:242-49
121. Schmidt HHW, Pollock JS, Nakane M, Gorsky LD, Förstermann U, et al. 1991. Purification of a soluble isoform of guanylyl cyclase-activating-factor synthase. Proc. Natl. Acad. Sci. USA 88: 365-69
122. 2+/calmodulin-independent diaphorase and reductase activities. Biochemistry 31:3423-49
123. 2+-independent nitric oxide synthase in the myocardium. Br. J. Pharmacol. 105:575-80
124. Sessa WC. 1994. The nitric oxide synthase family of proteins. J. Vasc. Res. 31:131-43
125. Sessa WC, Harrison JK, Barber CM, Zeng D, Durieux ME, et al. 1992. Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J. Biol. Chem. 267: 15274-76
126. Sherman PA, Laubach VE, Reep BR, Wood ER. 1993. Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line. Biochemistry 32:11600-5
127. Sheta EA, McMillan K, Masters BSS. 1994. Evidence for a biodomain structure of constitutive cerebellar nitric oxide synthase. J. Biol. Chem. 269: 15147-53
128. Stadler J, Bergonia HA, Di Silvio M, Sweetland MA, Billiar TR, et al. 1993. Nonheme iron-nitrosyl complex formation in rat hepatocytes: detection by electron paramagnetic resonance spectroscopy. Arch. Biochem. Biophys. 302: 4-11
129. Stamler JS. 1994. S-nitrosothiols and the bioregulatory actions of nitrogen ox-ides through reactions with thiol groups. Curr. Top. Immunol. Microbiol. In press
130. Stuehr DJ, Cho HJ, Kwon NS, Weise M, Nathan CF. 1991. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: a FAD- and FMN-containing flavoprotein. Proc. Natl. Acad. Sci. USA 88:7773-77
131. Stuehr DJ, Griffith OW. 1992. Mammalian nitric oxide synthase. Adv. Enzymol. Rel. Areas Mol. Biol. 65:287-346
132. Stuehr DJ, Gross SS, Sakuma I, Levi R, Nathan CF. 1989. Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide. J. Exp. Med. 169:1011-20
133. Stuehr DJ, Ikeda-Saito M. 1992. Spectral characterization of brain and macrophage nitric oxide synthase. Cytochrome P-450-like heme proteins that contain a flavin semiquinone radical. J. Biol. Chem. 267:20547-50
134. ω-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J. Biol. Chem. 266: 6259-63
135. Stuehr DJ, Marietta MA. 1985. Mammalian nitrate biosynthesis: mouse macrophages produce nitrate and nitrite in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. USA 82:7738-42
136. 131a. Stuehr DJ, Nathan CF. 1989. Nitric oxide. A macrophage product responsible for the cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169:1543-55
137. Szabo C, Thiemermann C. 1993. Potential therapeutic use of nitric oxide synthase inhibitors. Curr. Opin. Invest. Drugs 2:1165:74
138. Tracey WR, Pollock JS, Murad F, Nakane M, Förstermann U. 1994. Identification of an endothelial-like type III NO synthase in LLC-PK1 kidney epithelial cells. Am. J. Physiol. 266:C22-28
139. G-monomethyl-L-arginine. J. Exp. Med. 179:651-60
140. White KA, Marietta MA. 1992. Nitric oxide synthase is a cytochrome P-450 type hemoprotein. Biochemistry 31: 6627-31
141. Wink DA, Darby shire JF, Nims RW, Saavedra JE, Ford PC. 1993. Reactions of the bioregulatory agent nitric oxide in oxygenated aqueous media: determination of the kinetics for oxidation and nitrosation by intermediates generated in the NO/O2 reaction. Chem. Res. Toxicol. 6:23-27
142. Wolff DJ, Datto GA, Samatovicz RA. 1993. The dual mode of inhibition of calmodulin-dependent nitric oxide synthase by antifungal imidazole agents. J. Biol. Chem. 268:9430-36
143. Wolff DJ, Datto G A, Samatovicz RA, Tempsick RA. 1993. Calmodulin-dependent nitric oxide synthase. J. Biol. Chem. 268:9425-29
144. Wolff DJ, Gribin BJ. 1994. The inhibition of the constitutive and inducible nitric oxide synthase isoforms by indazole agents. Arch. Biochem. Biophys. 311:300-6
145. Wolff DJ, Gribin BJ. 1994. Interferon-γ-inducible murine macrophage nitric oxide synthase: studies on the mechanism of inhibition by imidazole agents. Arch. Biochem. Biophys. 311:293-99
146. Wolff DJ, Lubeski A, Umansky SC. 1994. The inhibition of the constitutive bovine endothelial nitric oxide synthase by imidazole and indazole agents. Arch. Biochem. Biophys. 314:360-66
147. Wood ER, Berger H Jr, Sherman PA, Lapetina EG. 1993. Hepatocytes and macrophages express an identical cytokine inducible nitric oxide synthase gene. Biochem. Biophys. Res. Commun. 191:767-74
148. Xie QW, Cho HJ, Calycay J, Mumford RA, Swiderek KM, et al. 1992. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256:225-28
149. Yui Y, Hattori R, Kosuga K, Eizawa H, Hiki K, et al. 1991. Purification of nitric oxide synthase from rat macrophages. J. Biol. Chem. 266:12544-47